论文信息 - Cetuximab in combination with cisplatin and docetaxel as first-line treatment in patients with locally advanced or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma (Italian phase II DOCETUX study)

Cetuximab in combination with cisplatin and docetaxel as first-line treatment in patients with locally advanced or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma (Italian phase II DOCETUX study)

4575 Background: The aim of this study was to evaluate the efficacy and safety of cetuximab in combination with cisplatin and docetaxel as first-line treatment for advanced gastric or GEJ cancer. M...